GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portage Biotech Inc (NAS:PRTG) » Definitions » Cyclically Adjusted Book per Share

PRTG (Portage Biotech) Cyclically Adjusted Book per Share : $288.71 (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Portage Biotech Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Portage Biotech's adjusted book value per share for the three months ended in Sep. 2024 was $1.253. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $288.71 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Portage Biotech's average Cyclically Adjusted Book Growth Rate was 1.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 4.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Portage Biotech was 10.20% per year. The lowest was -14.70% per year. And the median was 2.75% per year.

As of today (2025-04-13), Portage Biotech's current stock price is $8.59. Portage Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was $288.71. Portage Biotech's Cyclically Adjusted PB Ratio of today is 0.03.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Portage Biotech was 0.03. The lowest was 0.00. And the median was 0.00.


Portage Biotech Cyclically Adjusted Book per Share Historical Data

The historical data trend for Portage Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portage Biotech Cyclically Adjusted Book per Share Chart

Portage Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 243.28 240.16 260.34 277.56 287.12

Portage Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 284.45 282.74 287.12 288.23 288.71

Competitive Comparison of Portage Biotech's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Portage Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Portage Biotech's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Portage Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Portage Biotech's Cyclically Adjusted PB Ratio falls into.


;
;

Portage Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Portage Biotech's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book= Book Value per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=1.253/133.0289*133.0289
=1.253

Current CPI (Sep. 2024) = 133.0289.

Portage Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201412 27.136 99.070 36.438
201503 25.825 99.621 34.485
201506 58.236 100.684 76.944
201509 50.650 100.392 67.116
201512 65.463 99.792 87.266
201603 80.858 100.470 107.061
201606 92.055 101.688 120.427
201609 359.425 101.861 469.404
201612 312.126 101.863 407.625
201703 458.415 102.862 592.856
201706 1,207.841 103.349 1,554.709
201709 1,800.318 104.136 2,299.831
201712 1,290.203 104.011 1,650.154
201803 68.707 105.290 86.808
201806 67.400 106.317 84.334
201809 65.921 106.507 82.337
201812 64.136 105.998 80.492
201903 183.562 107.251 227.682
201906 180.888 108.070 222.665
201909 178.958 108.329 219.761
201912 179.552 108.420 220.306
202003 175.831 108.902 214.787
202006 175.764 108.767 214.970
202009 169.260 109.815 205.040
202012 173.750 109.897 210.323
202103 167.962 111.754 199.937
202106 191.758 114.631 222.534
202109 190.615 115.734 219.099
202112 188.589 117.630 213.278
202203 181.717 121.301 199.286
202206 180.662 125.017 192.240
202209 210.666 125.227 223.792
202212 197.828 125.222 210.162
202303 86.415 127.348 90.270
202306 82.460 128.729 85.215
202309 76.024 129.860 77.879
202312 32.355 129.419 33.257
202403 4.067 131.776 4.106
202406 2.394 132.554 2.403
202409 1.253 133.029 1.253

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Portage Biotech  (NAS:PRTG) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Portage Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=8.59/288.71
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Portage Biotech was 0.03. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Portage Biotech Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Portage Biotech's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Portage Biotech Business Description

Industry
Traded in Other Exchanges
N/A
Address
Clarence Thomas Building, P.O. Box 4649, Tortola, Road Town, VGB, VG1110
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.